Cargando…

Elaiophylin Is a Potent Hsp90/ Cdc37 Protein Interface Inhibitor with K-Ras Nanocluster Selectivity

The natural product elaiophylin is a macrodiolide with a broad range of biological activities. However, no direct target of elaiophylin in eukaryotes has been described so far, which hinders a systematic explanation of its astonishing activity range. We recently showed that the related conglobatin A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siddiqui, Farid A., Vukic, Vladimir, Salminen, Tiina A., Abankwa, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229862/ https://www.ncbi.nlm.nih.gov/pubmed/34199986 http://dx.doi.org/10.3390/biom11060836

Ejemplares similares

Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-Signaling
por: Siddiqui, Farid Ahmad, et al.
Publicado: (2021)

Design of Disruptors of the Hsp90–Cdc37 Interface
por: D’Annessa, Ilda, et al.
Publicado: (2020)

Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery
por: Li, Ting, et al.
Publicado: (2018)

Therapeutic Potential of the Hsp90/Cdc37 Interaction in Neurodegenerative Diseases
por: Gracia, Liam, et al.
Publicado: (2019)

Assembly mechanism of early Hsp90-Cdc37-kinase complexes
por: Keramisanou, Dimitra, et al.
Publicado: (2022)

Nematode CDC-37 and DNJ-13 form complexes and can interact with HSP-90
por: Schmauder, Lukas, et al.
Publicado: (2021)

Hsp90-Dependent Activation of Protein Kinases Is Regulated by Chaperone-Targeted Dephosphorylation of Cdc37
por: Vaughan, Cara K., et al.
Publicado: (2008)

Cell Surface Cdc37 Participates in Extracellular HSP90 Mediated Cancer Cell Invasion
por: El Hamidieh, Avraam, et al.
Publicado: (2012)

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins
por: Smith, Jennifer R., et al.
Publicado: (2013)

Differential Regulation of G1 CDK Complexes by the Hsp90-Cdc37 Chaperone System
por: Hallett, Stephen T., et al.
Publicado: (2017)

HSP90-CDC37-PP5 forms a structural platform for kinase dephosphorylation
por: Oberoi, Jasmeen, et al.
Publicado: (2022)

Silencing the cochaperone CDC37 destabilises kinase clients and sensitises cancer cells to HSP90 inhibitors
por: Smith, Jennifer R., et al.
Publicado: (2008)

Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer
por: Wang, Lei, et al.
Publicado: (2019)

Stability of the Human Hsp90-p50(Cdc37) Chaperone Complex against Nucleotides and Hsp90 Inhibitors, and the Influence of Phosphorylation by Casein Kinase 2
por: Olesen, Sanne H., et al.
Publicado: (2015)

Hsp90 S-nitrosylation at Cys521, as a conformational switch, modulates cycling of Hsp90-AHA1-CDC37 chaperone machine to aggravate atherosclerosis
por: Zhao, Shuang, et al.
Publicado: (2022)

ASPP2 Is a Novel Pan-Ras Nanocluster Scaffold
por: Posada, Itziar M. D., et al.
Publicado: (2016)

Triple knockdown of CDC37, HSP90-alpha and HSP90-beta diminishes extracellular vesicles-driven malignancy events and macrophage M2 polarization in oral cancer
por: Ono, Kisho, et al.
Publicado: (2020)

The co-chaperone Cdc37 regulates the rabies virus phosphoprotein stability by targeting to Hsp90AA1 machinery
por: Xu, Yunbin, et al.
Publicado: (2016)

FW-04-806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation
por: Huang, Wei, et al.
Publicado: (2014)

Natural Occurrence, Bioactivity and Biosynthesis of Elaiophylin Analogues
por: Gui, Min, et al.
Publicado: (2019)

Disease Variants of FGFR3 Reveal Molecular Basis for the Recognition and Additional Roles for Cdc37 in Hsp90 Chaperone System
por: Bunney, Tom D., et al.
Publicado: (2018)

Rational design, synthesis and structural characterization of peptides and peptidomimetics to target Hsp90/Cdc37 interaction for treating hepatocellular carcinoma
por: Sukumaran, Surya, et al.
Publicado: (2023)

Mutations Y493G and K546D in human HSP90 disrupt binding of celastrol and reduce interaction with Cdc37
por: Peng, Bin, et al.
Publicado: (2016)

Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90
por: Zhao, Ming, et al.
Publicado: (2011)

Halichoblelide D, a New Elaiophylin Derivative with Potent Cytotoxic Activity from Mangrove-Derived Streptomyces sp. 219807
por: Han, Ying, et al.
Publicado: (2016)

Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis
por: Lim, Haet Nim, et al.
Publicado: (2018)

Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering
por: Blaževitš, Olga, et al.
Publicado: (2016)

Opposite feedback from mTORC1 to H-ras and K-ras4B downstream of SREBP1
por: Posada, Itziar M. D., et al.
Publicado: (2017)

Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentation
por: Šolman, Maja, et al.
Publicado: (2015)

Lipid Profiles of RAS Nanoclusters Regulate RAS Function
por: Zhou, Yong, et al.
Publicado: (2021)

NRAS is unique among RAS proteins in requiring ICMT for trafficking to the plasma membrane
por: Ahearn, Ian M, et al.
Publicado: (2021)

Hsp90/Cdc37 Chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A
por: Grover, Abhinav, et al.
Publicado: (2011)

(20S) Ginsenoside Rh2 Exerts Its Anti-Tumor Effect by Disrupting the HSP90A-Cdc37 System in Human Liver Cancer Cells
por: Chen, Chen, et al.
Publicado: (2021)

Structural Bioinformatics and Protein Docking Analysis of the Molecular Chaperone-Kinase Interactions: Towards Allosteric Inhibition of Protein Kinases by Targeting the Hsp90-Cdc37 Chaperone Machinery
por: Lawless, Nathan, et al.
Publicado: (2013)

Ensemble-based modeling and rigidity decomposition of allosteric interaction networks and communication pathways in cyclin-dependent kinases: Differentiating kinase clients of the Hsp90-Cdc37 chaperone
por: Stetz, Gabrielle, et al.
Publicado: (2017)

Mechanisms of Ras Membrane Organization and Signaling: Ras Rocks Again
por: Abankwa, Daniel, et al.
Publicado: (2020)

Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin
por: Zheng, Jianwei, et al.
Publicado: (2020)

Elaiophylin reduces body weight and lowers glucose levels in obese mice by activating AMPK
por: Bao, Ruoxuan, et al.
Publicado: (2021)

Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells
por: ZITZMANN, KATHRIN, et al.
Publicado: (2013)

Promotion of cancer cell stemness by Ras
por: Chippalkatti, Rohan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_32r520pn3uq1kpjet38atdghpq